STERIS’ (TSE:STE – Get Free Report) was upgraded by Cormark to a “moderate buy” rating in a report issued on Monday,Zacks.com reports.
Separately, Atb Cap Markets upgraded STERIS’ to a “strong-buy” rating in a research report on Sunday, December 22nd.
Get Our Latest Research Report on STE
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Recommended Stories
- Five stocks we like better than STERIS’
- Best Stocks Under $10.00
- 100% Upside? Amprius Technologies Is Charged for Growth in 2025
- Using the MarketBeat Stock Split Calculator
- The 5 Stocks Congress Bought Most in 2024: Top Picks for 2025
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks Set to Benefit From Trump’s “Drill, Baby, Drill” Policy
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
